CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Return
34.55%
This Quarter Return
+20.45%
1 Year Return
+34.55%
3 Year Return
+41.71%
5 Year Return
+124.92%
10 Year Return
+254.42%
AUM
$108B
AUM Growth
+$20.3B
(+23%)
Cap. Flow
+$2.04B
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
19.41%
Holding
3,615
New
232
Increased
1,747
Reduced
1,114
Closed
297
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.14B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Amazon
AMZN
|
+$1.05B |
| 4 |
Otis Worldwide
OTIS
|
+$576M |
| 5 |
Trip.com Group
TCOM
|
+$538M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$1.9B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$993M |
| 3 |
Linde
LIN
|
+$639M |
| 4 |
McKesson
MCK
|
+$342M |
| 5 |
Visa
V
|
+$339M |
Sector Composition
| 1 | Technology | 22.32% |
| 2 | Healthcare | 14.29% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.34% |
| 5 | Communication Services | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Stride
LRN
$6.89B
| $28.2M | 0.02% |
1,034,217
+1,005,286
| +3,475% | +$27.4M |
|
|
HR
602
DELISTED
Healthcare Realty Trust Incorporated
HR
| $28.2M | 0.02% |
961,638
+749,185
| +353% | +$21.9M |
|
603
Cencora
COR
$57.4B
| $28M | 0.02% |
278,125
+11,535
| +4% | +$1.16M |
|
604
Huron Consulting
HURN
$2.36B
| $27.7M | 0.02% |
626,922
+26,411
| +4% | +$1.17M |
|
605
Arch Capital
ACGL
$33.8B
| $27.7M | 0.02% |
965,629
-31,705
| -3% | -$908K |
|
606
Equity Lifestyle Properties
ELS
$11.7B
| $27.7M | 0.02% |
442,710
-21,992
| -5% | -$1.37M |
|
607
Everest Group
EG
$14.3B
| $27.5M | 0.02% |
133,580
-40,259
| -23% | -$8.3M |
|
608
Fate Therapeutics
FATE
$115M
| $27.5M | 0.02% |
802,194
+108,778
| +16% | +$3.73M |
|
609
iShares Short Treasury Bond ETF
SHV
$20.7B
| $27.5M | 0.02% |
248,249
-37,711
| -13% | -$4.18M |
|
610
GDS Holdings
GDS
$6.42B
| $27.4M | 0.02% |
344,232
+40,525
| +13% | +$3.23M |
|
611
Roku
ROKU
$14B
| $27.3M | 0.02% |
234,055
+72,042
| +44% | +$8.39M |
|
612
Invitation Homes
INVH
$18.4B
| $27.3M | 0.02% |
990,141
-263,801
| -21% | -$7.26M |
|
613
West Pharmaceutical
WST
$18.4B
| $27.2M | 0.02% |
119,808
+10,116
| +9% | +$2.3M |
|
|
AXDX
614
DELISTED
Accelerate Diagnostics
AXDX
| $27M | 0.02% |
178,371
-120,416
| -40% | -$18.3M |
|
|
QTNT
615
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $27M | 0.02% |
91,118
+22,810
| +33% | +$6.75M |
|
616
FibroGen
FGEN
$46.5M
| $26.9M | 0.02% |
26,578
+4,640
| +21% | +$4.7M |
|
617
Owens Corning
OC
$12.8B
| $26.9M | 0.02% |
482,562
-23,711
| -5% | -$1.32M |
|
618
W.R. Berkley
WRB
$27.4B
| $26.9M | 0.02% |
1,054,532
+72,027
| +7% | +$1.83M |
|
619
UDR
UDR
$12.7B
| $26.8M | 0.02% |
715,873
-153,375
| -18% | -$5.73M |
|
620
Evolent Health
EVH
$1.07B
| $26.7M | 0.02% |
3,752,082
+8,844
| +0.2% | +$63K |
|
621
Brown & Brown
BRO
$30.5B
| $26.5M | 0.02% |
649,249
+123,099
| +23% | +$5.02M |
|
622
Markel Group
MKL
$24.3B
| $26.3M | 0.02% |
28,513
+382
| +1% | +$353K |
|
623
American Airlines Group
AAL
$8.46B
| $26.3M | 0.02% |
2,011,965
+267,240
| +15% | +$3.49M |
|
624
Thomson Reuters
TRI
$76.8B
| $26.2M | 0.02% |
371,301
-398,980
| -52% | -$28.1M |
|
625
Sonoco
SON
$4.54B
| $26.1M | 0.02% |
498,932
+7,013
| +1% | +$367K |
|